Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
sotatercept
Biotech
Chiesi buys into Gossamer's Winrevair rival
Chiesi's investment throws a lifeline to Gossamer a year after it laid off staff to save money.
Max Bayer
May 6, 2024 10:28am
Diagonal launches with $128M to grow agonist antibody platform
Apr 3, 2024 6:00am
The 10 highest value R&D projects in biopharma
Sep 5, 2023 6:00am
Merck reveals HIV combo trial is back in the running
Apr 27, 2023 11:27am
Gossamer pauses CNS med enrollment, citing risk-benefit profile
Mar 17, 2023 11:16am
Merck cardio plan forms as sotatercept, PCSK9 inhibitor impress
Mar 6, 2023 12:00pm
